Cell Source, Inc.

CLCS · OTC · SIC 2834: Pharmaceutical Preparations
75
SEC Filings
$0.5299
Close 2026-10-28

Business Summary

Cell Source, Inc. is a Nevada-based cell therapy company focused on immunotherapy. It develops proprietary immune system management technology licensed from Yeda Research & Development (Weizmann Institute). Its core Veto Cell technology enables haploidentical hematopoietic stem cell transplantation (HSCT) under mild conditioning, aiming to prevent GvHD, graft rejection, and viral infections. The company also pursues VETO CAR-T therapy, combining Veto Cell technology with allogeneic CAR-T cell therapy for blood cancer treatment.

Latest Stock Quote

CLCS 2026-10-28 $0.5299 O:$0.46495 H:$0.5299 L:$0.46495 Vol:0.0M VWAP:$0.4771
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-07-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2024-06-242023-12-310001493152-24-024903EDGAR78K words
2023-08-082022-12-310001493152-23-027069EDGAR75K words
2022-04-152021-12-310001493152-22-010133EDGAR77K words
2021-04-152020-12-310001640334-21-000923EDGAR75K words
2020-03-302019-12-310001640334-20-000672EDGAR63K words
2019-04-012018-12-310001165527-19-000034EDGAR60K words
2018-07-252017-12-310001165527-18-000154EDGAR75K words
2016-04-142015-12-310001165527-16-000733EDGAR65K words
2015-03-132014-12-310001144204-15-015954EDGAR61K words
2014-03-252013-12-310001165527-14-000161EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2024-11-142024-09-300001493152-24-045964EDGAR23K words
2024-08-192024-06-300001493152-24-033055EDGAR20K words
2024-07-292024-03-310001493152-24-029448EDGAR16K words
2023-11-092023-09-300001493152-23-040079EDGAR21K words
2023-09-192023-06-300001493152-23-033011EDGAR19K words
2023-08-232023-03-310001493152-23-029915EDGAR16K words
2022-12-082022-09-300001493152-22-034876EDGAR20K words
2022-12-022022-06-300001493152-22-034255EDGAR18K words
2022-11-022022-03-310001493152-22-030233EDGAR15K words
2021-11-152021-09-300001493152-21-028675EDGAR23K words
2021-08-122021-06-300001493152-21-019491EDGAR18K words
2021-05-172021-03-310001493152-21-011971EDGAR15K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-06-270001641172-25-016833EDGAR1K words
2024-04-090001493152-24-014035EDGAR0K words
2022-07-210001493152-22-019997EDGAR0K words
2022-05-060001493152-22-012387EDGAR0K words
2022-03-110001493152-22-006672EDGAR1K words
2021-04-020001640334-21-000755EDGAR1K words
2019-04-190001165527-19-000053EDGAR0K words
2015-11-160001165527-15-000545EDGAR1K words
2015-11-050001165527-15-000524EDGAR1K words
2015-08-190001165527-15-000418EDGAR1K words

75 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

hematological-malignancies-(blood-cancers) allogeneic-hematopoietic-stem-cell-transplantation-(hsct) car-t-cell-therapy organ-transplantation non-malignant-hematological-conditions

Company Identity

CIK0001569340
TickerCLCS
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersHouston, Texas

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 3e6677ad631b1b82b9c548fede7af484e0b80ffe2919525c57bee78cabccc03a
parent: 9f301d4b67eeebd331b5c7ad13a9ed1f6786d8cd18630720110b88ddaf351f1d
content hash: 094fd7338f37b950af7c0d1ecd749153b8162ff30c66a9762d4d12403ae6284e
signed: 2026-11-16T19:01:21.526Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CLCS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CLCS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CLCS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.